epro-995x60.png
FEATURED ARTICLES
-
FDA's Draft Guidance On Bayesian Methods: Strategic Implications For Small Biotechs
The FDA draft guidance on Bayesian methodology represents a major validation of statistical innovation in clinical development. Jessica Cordes summarizes the latest from the FDA and offers advice for small biotechs.
-
How Regulatory Convergence Is Rewriting Clinical Data Management
Regulatory shifts toward structured, digital clinical trial protocols are reducing manual interpretation, enabling risk-based oversight, and supporting more efficient, transparent, end-to-end trial execution.
-
Sponsor-Provided Source Templates: Your Questions Answered
See how centralized eSource improves trial operations through faster startup, better data quality, and real‑time protocol guidance. An expert Q&A offers practical tips for sponsors, sites, and CROs.
WHITE PAPERS AND CASE STUDIES
-
Visit Management Solution Built For Global Trials
From reminders to resource coordination, visit scheduling shouldn't slow trials down. Discover how automation can reduce deviations and support participants.
-
An eConsent Platform For Modern Clinical Trials
From signature to re-consent, manual processes add delay and risk. Discover how a digital approach to informed consent keeps studies compliant, on track, and participant-focused.
-
Modern eConsent Built For Clinical Research Sites
We partnered with leading academic medical centers, sponsors, hospital systems, and site networks to create an eConsent platform that is easy-to-use and minimizes risk.
NEWS
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
- Exco InTouch Joins Critical Path Institute ePRO Consortium To Advance Electronic Data Capture In Clinical Trials
- ERT Expands Corporate Presence In Japan